• Patient Education

Patient Education: Daratumumab & Daratumumab and Hyaluronidase-fihj - Monoclonal Ab - Immunotherapy

Patient Education: Daratumumab & Daratumumab and Hyaluronidase-fihj

Daratumumab

DARATUMUMAB (DARZALEX)


NIH National cancer institute - cancer.gov site info

This page contains brief information about daratumumab and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s): Darzalex

FDA Approved: Yes

Learn more: https://www.cancer.gov/about-cancer/treatment/drugs/daratumumab

 

MedlinePlus Information

A lay language summary of important information about this drug that may include the following:

warnings about this drug,

what this drug is used for and how it is used,

what you should tell your doctor before using this drug,

what you should know about this drug before using it,

other drugs that may interact with this drug, and

possible side effects.

Learn more: https://medlineplus.gov/druginfo/meds/a616002.html

 

Information on Darzalex website

Preparing for Treatment | DARZALEX® (daratumumab)

https://www.darzalex.com/darzalex-treatment/preparing-for-treatment




DARATUMUMAB AND HYALURONIDASE-FIHJ (DARZALEX FASPRO)



NIH National cancer institute - cancer.gov site info

This page contains brief information and collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s): Darzalex Faspro

FDA Approved: Yes

Learn more: https://www.cancer.gov/about-cancer/treatment/drugs/daratumumabandhyaluronidase-fihj

 

MedlinePlus Information

A lay language summary of important information about this drug that may include the following:

warnings about this drug,

what this drug is used for and how it is used,

what you should tell your doctor before using this drug,

what you should know about this drug before using it,

other drugs that may interact with this drug, and

possible side effects.

Learn more: https://medlineplus.gov/druginfo/meds/a620040.html

 

Information on Darzalex Faspro Site:

https://news.darzalex.com/faspro/#how-is-darzalex-faspro-given

 

INTERNATIONAL MYELOMA FOUNDATION:


Understanding DARZALEX and DARZALEX FASPRO

https://www.myeloma.org/resource-library/understanding-darzalexr-darzalex-fasprotm

Download Booklet here


IMF Understanding Series

https://www.myeloma.org/cancer-information-series


IMF Resource Library

https://www.myeloma.org

https://www.myeloma.org/publications-videos

https://www.youtube.com/c/IMFMyeloma/videos


Current FDA-Approved Medications for Multiple Myeloma Treatment

https://www.myeloma.org/multiple-myeloma-drugs

 

HEALTH TREE UNIVERSITY MYELOMA:


All About Darzalex (daratumumab)

Watch Video on YouTube


HealthTree University for Multiple Myeloma Lectures

https://healthtree.org/myeloma/university/courses

https://healthtree.org/


HealthTree University Myeloma Videos

https://www.youtube.com/c/HealthTreeUniversity/videos

 

MULTIPLE MYELOMA RESERACH FOUNDATION:


Standard Treatments - Darzalex/Darzalex Faspro

Darzalex/Darzalex Faspro

https://themmrf.org/multiple-myeloma/treatment-options/standard-treatments/


MMRF Education Programs

https://themmrf.org/resources/education-programs/

https://themmrf.org/


MMRF Videos

https://www.youtube.com/user/TheMMRF/videos

 

References DARZALEX & DARZALEX FASPRO:


FDA Label Prescribing Information (Revised 03/2022)

Prescribing Information | DARZALEX FASPRO

label (fda.gov)


FDA Label Prescribing Information (Revised 01/2022)

Prescribing Information | DARZALEX

label (fda.gov)


Drug Label Information at DAILYMED - NIH-National Library of Medicine

DailyMed - DARZALEX FASPRO (daratumumab and hyaluronidase-fihj- human recombinant injection


DailyMed - DARZALEX- daratumumab injection, solution, concentrate


Other Resources

Patient and caregiver resources

 

- Multiple Myeloma Patient Education & Information on ongoing Multiple Myeloma Clinical Trials -


Posts Archive